萌芽的心
发表于 2025-3-21 16:06:59
书目名称Small Molecule Therapeutics for Schizophrenia影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0868495<br><br> <br><br>书目名称Small Molecule Therapeutics for Schizophrenia读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0868495<br><br> <br><br>
Ophthalmologist
发表于 2025-3-21 20:57:19
http://reply.papertrans.cn/87/8685/868495/868495_2.png
placebo-effect
发表于 2025-3-22 03:41:43
978-3-319-37894-7Springer International Publishing Switzerland 2015
朝圣者
发表于 2025-3-22 06:55:36
http://reply.papertrans.cn/87/8685/868495/868495_4.png
凶兆
发表于 2025-3-22 09:20:10
http://reply.papertrans.cn/87/8685/868495/868495_5.png
阻碍
发表于 2025-3-22 16:30:51
,Antipsychotics and the Dopamine–Serotonin Connection,ly slightly improved this situation. The vast majority of antipsychotics bind to dopamine as well as serotonin receptors, and it has been suggested that the ratio between the affinities for these receptors may be crucial for the therapeutic properties. The aim of the present review is to evaluate th
僵硬
发表于 2025-3-22 20:59:31
GlyT-1 Inhibitors: From Hits to Clinical Candidates,T ligand development and their use in clinical development and the status of clinical-stage compounds will be addressed. Finally there is a discussion of some of the issues that have arisen with the discovery and development of GlyT-1 inhibitors and the prospects for the future of this mechanistic a
optic-nerve
发表于 2025-3-22 21:41:13
http://reply.papertrans.cn/87/8685/868495/868495_8.png
故意钓到白杨
发表于 2025-3-23 03:33:53
Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associatehesis of schizophrenia. The fine tuning of the functional activity and the clarification of biased signaling pathways in different chemical series may provide clues to achieve efficacy and a good safety profile for novel pharmacotherapies.
PAGAN
发表于 2025-3-23 07:41:12
http://reply.papertrans.cn/87/8685/868495/868495_10.png